Many Reasons to Buy Disney Stock
People all over the world love kind and colorful Disney cartoons. What if we say that you can both adore the pictures and trade stocks of the company that creates them?
S&P: hesitant, but still positive
2020-06-25 • Updated
The stock market is going through an interesting phase now. On the one hand, some of its areas – specifically, tech stocks - are booming which alerts observes about investors overconfidence. On the other hand, there is a definite dropdown in the overall performance caused by second-wave virus fears amid new outbreaks. Is the march upwards over then?
Definitely not.
The closer the S&P gets to the pre-virus levels, the more downward gravity it will experience.
Hence, the more horizontally-bent it’s trajectory will look like as it moves upwards to ful recovery.
For this reason, it would probably be unwise to expect the recovery keep the upward pace of March and fall into way too optimistic zone 2 – we are already out of that range.
More likely, zone 1 will be where the stock market will be going – it is the most balanced and moderate expectation.
Finally, zone 3 is also a possibility, at least as a bottom to the channel of zone 1 to which the S&P may drop from time to time.
The horizontal-gravity theory is confirmed indirectly by the fact that each sideways/downward retrace lasts longer: as you move from sector A to sector D (we are currently at the bottom of sector D), you have a longer protraction over time.
Therefore, there is no reason to panic. Yes, there are outbreaks but the fundamentals have not changed yet. Take zone 1 as a realistic expectation of where the S&P goes in the nearest midterm and prepare for zone 3 to provide support at 3,000 for a while ahead.
Similar
How Alibaba Deals with Troubled Times?
The e-commerce giant has recently faced a lot of pressure, starting from global uncertainty in China amid lockdowns and geopolitics. The company has been added to the US SEC (Securities and Exchange Commission) delisting queue. Finally, there’s an earnings report coming on August 4. Let’s discuss everything and prepare for the next move.
Inovio to Plunge Ahead of Earnings Report
About the company Inovio Pharmaceuticals Inc (INO) is a biotechnology company that focuses on developing DNA immunotherapies and vaccines to treat and prevent various cancers and infectious diseases…
Latest news
The CAD vs. the World: Mid-Term Scenarios for the Currency
In the middle of September 2022, the Canadian dollar has fallen to a 2-year low against the USD
Fed Keeps Pushing USD to 2000s Highs
The US dollar index has all chances of reaching the 2000s high of 120.00.
Canadian CPI, Top-down Analysis and Trade Ideas
The Consumer Price Index announcement by Statistics Canada is set for release in a few hours will reveal the state of inflation in the Canadian economy
